Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 369 (6478), 318-20

Activation of C. Elegans Cell Death Protein CED-9 by an Amino-Acid Substitution in a Domain Conserved in Bcl-2

Affiliations

Activation of C. Elegans Cell Death Protein CED-9 by an Amino-Acid Substitution in a Domain Conserved in Bcl-2

M O Hengartner et al. Nature.

Abstract

The Caenorhabditis elegans gene ced-9 and the human proto-oncogene bcl-2, both of which protect cells from programmed cell death, are members of the same gene family. ced-9 and bcl-2 were discovered because of the effects of dominant gain-of-function mutations. Such bcl-2 mutations, which are commonly found in follicular lymphoma, are translocations that result in over-expression of a normal Bcl-2 protein in B cells. Here we report that, by contrast, the ced-9(n1950) gain-of-function mutation affects the open reading frame of ced-9 and results in a glycine-to-glutamate substitution in a region highly conserved among all ced-9/bcl-2 family members. We conclude that this glycine has an important function in ced-9 regulation, and we suggest that alteration of this glycine in other members of the ced-9/bcl-2 family might lead to oncogenic activation. We also present genetic evidence suggesting that the CED-9 protein might exist in two distinct forms that have opposite effects on cell death.

Comment in

Similar articles

See all similar articles

Cited by 36 PubMed Central articles

See all "Cited by" articles

Publication types

MeSH terms

LinkOut - more resources

Feedback